HIPEC is a specialised treatment that combines surgery with heated chemotherapy to target microscopic cancer cells remaining in the abdominal cavity after tumour removal.
Building on its experience, Kauvery Hospital is launching a dedicated centre for HIPEC and Cytoreductive Surgery to advance abdominal cancer care.
Chennai, November 18th, 2026: Kauvery Hospital has completed over 200 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedures, making it one of the few hospitals in the state with this level of experience in treating cancers that have spread to the lining of the abdomen (peritoneum).
Building on this experience, Kauvery Hospital has also launched a dedicated centre for HIPEC and Cytoreductive Surgery to further strengthen its expertise in treating advanced abdominal cancers.
HIPEC delivers heated chemotherapy directly into the abdominal cavity during cytoreductive surgery, the operation that aims to remove all visible tumour deposits. Its main purpose is to kill microscopic cancer cells that remain after the surgery. Combining the two allows concentrated treatment at the disease site, with less of the drug reaching the rest of the body.
The treatment is performed in carefully selected patients with cancers that have spread within the abdominal cavity, including ovarian and colorectal cancers, as well as other cancers affecting the abdominal lining.
HIPEC is offered only at select centres in the country, as it is a team-based, resource-intensive treatment requiring a highly trained multidisciplinary team, specialised equipment and careful patient selection. The team comprises surgical oncologists, medical oncologists, anaesthetists, intensivists, pathologists, radiologists and nutritionists, supported by nursing staff experienced in caring for these patients.
Expertise in cytoreductive surgery is particularly crucial, as treatment outcomes depend significantly on how completely the surgeon removes visible cancer deposits from the abdominal cavity. Advanced imaging and, where necessary, laparoscopic staging help assess the extent of disease spread and identify patients who are most likely to benefit from the procedure.
The procedure also requires specialised perfusion machines that heat the chemotherapy solution to approximately 41-43°C, circulate it within the abdominal cavity and continuously monitor its temperature. Since the surgery is prolonged and can involve considerable blood loss and heat stress, an experienced anaesthesia and critical care team is equally essential.
Commenting on the milestone, Dr. Sujay Susikar, Senior Consultant Surgical Oncology, Kauvery Hospital, said, “We are happy to have crossed the milestone of 200 HIPEC procedures, which reflects our team’s experience and commitment to delivering advanced cancer care. HIPEC offers an important treatment option for patients with advanced cancers that have spread to the peritoneum, a condition that was once considered extremely difficult to treat. Conventional intravenous chemotherapy may not adequately reach cancer deposits in this region. HIPEC addresses this limitation by circulating heated chemotherapy directly within the abdominal cavity following surgery to remove visible tumours. This helps target microscopic cancer cells that may remain after surgery, improving treatment possibilities for carefully selected patients who previously had very limited options.”
In his comments, Dr Aravindan Selvaraj, Co Founder and Executive Director, Kauvery Group of Hospitals, said, “Advanced abdominal cancers have always been among the most challenging to treat. With HIPEC, we are able to extend meaningful treatment options for patients who earlier had very limited choices. At Kauvery Hospital, our focus has been on combining the right infrastructure, clinical expertise, and a multidisciplinary approach to deliver outcomes that truly make a difference in patients’ lives. This integrated approach has also enabled us to care for patients from across geographies, who place their trust in our team for complex cancer treatment.”
The new initiative integrates robotic rehabilitation and advanced neurostimulation technologies to support individuals through different stages of stroke recovery.
Chennai, 11th November 2026: Recognising that stroke recovery extends well beyond emergency treatment and medical stabilisation, Kauvery Hospital, Alwarpet, is strengthening its rehabilitation services with the introduction of advanced robotic and technology-assisted rehabilitation systems. This initiative aims to provide a structured, comprehensive and patient-centred approach to stroke rehabilitation, helping patients work towards regaining movement, improving functional abilities and achieving greater independence in everyday activities.
Kauvery Hospital has a dedicated 24/7 Stroke Care Unit, supported by a multidisciplinary team of specialists and trained healthcare professionals to manage stroke patients through different stages of care. The team includes stroke medicine specialists, interventional radiologists, neurosurgeons and Rapid Neuro ICU intensivists, working in coordination to provide timely assessment, appropriate treatment and critical care when required. The dedicated stroke unit is supported by trained nursing staff and advanced medical equipment to facilitate comprehensive stroke management. From emergency evaluation and acute intervention to critical care and subsequent rehabilitation, this integrated approach aims to ensure continuity of care throughout the patient’s journey. By introducing Stroke Rehabilitation, the hospital will provide care beyond treatment.
Speaking about the importance of rehabilitation in stroke care, Dr. Sivarajan Thandeswaran, Senior Consultant – Stroke Medicine, Kauvery Hospital Alwarpet, said, “Stroke treatment does not end with the initial medical intervention. The recovery phase is equally important, as individuals may have to overcome challenges related to movement, balance, coordination and everyday activities. Rehabilitation requires consistent, repetitive and structured training, guided by a multidisciplinary team. The introduction of advanced robotic rehabilitation systems allows us to incorporate technology-assisted training into individualised rehabilitation programmes, helping them work towards improving their functional abilities and independence. Our focus is to make the recovery journey more structured and meaningful for every individual.”
One of the key additions is the Multilimb Isokinetic Robotic Rehabilitation System , a computerised robotic system designed to facilitate upper-limb, lower-limb and functional arm movement training. The system offers more than 20 exercise options for both upper and lower limbs, including exercises designed for major joints. It operates in active, assistive and resistive modes, allowing the level of support or resistance to be adapted to individual rehabilitation requirements.
The system also supports training for Activities of Daily Living (ADL), helping patients practise functional movements relevant to everyday tasks. Its interactive approach enables structured movement practice, with flexibility to address different stages of rehabilitation.
For those experiencing difficulty with hand and finger movements, robotic hand rehabilitation gloves will support guided hand-opening, hand-closing and finger-movement exercises. The system incorporates passive and mirror-therapy modes, along with adjustable training settings. By facilitating repetitive and assisted hand movements, this technology can be incorporated into individualised hand rehabilitation programmes under professional supervision.
The integration of robotic rehabilitation technologies with conventional physiotherapy and occupational therapy will enable the clinical team to incorporate different forms of assisted, repetitive and resistance-based movement training into individualised rehabilitation programmes. These technologies complement, rather than replace, the expertise and guidance of rehabilitation professionals.
Commenting on the initiative, Dr. Aravindan Selvaraj, Co Founder & Executive Director, Kauvery Group of Hospitals, said, “At Kauvery, we believe that healthcare must extend beyond treating a medical condition to supporting patients throughout their journey towards recovery. Stroke can have a profound impact on an individual’s mobility, independence and quality of life, as well as on their families. By bringing advanced robotic rehabilitation and neurostimulation technologies into our rehabilitation services, we are strengthening our commitment to comprehensive stroke care. Our aim is to combine clinical expertise, appropriate technology and compassionate care to support patients at every stage of their recovery journey.”
About Kauvery Hospital
Kauvery Hospital is a leading multi-specialty healthcare provider in India, recognised for its commitment to clinical excellence, patient-centric care and advanced medical infrastructure. The hospital group operates a network of twelve hospitals across six key locations – Trichy, Chennai, Salem, Hosur, Tirunelveli and Bengaluru – and employs over 11,000 healthcare professionals. Serving millions of patients annually, Kauvery Hospital is dedicated to delivering high-quality secondary and tertiary care, supported by a strong focus on innovation, clinical outcomes and continuous advancement in healthcare delivery.
● Critical stage of a complex heart surgery completed in approximately 13 minutes, with the
patient discharged just five days after surgery.
Chennai, 3 rd November 2026: Prashanth Hospitals, one of South India’s leading super-speciality healthcare providers, has successfully performed a complex heart surgery to save the life of a 51-year- old patient with a severely enlarged aorta measuring 10.5 cm. The aorta, the main blood vessel that carries blood from the heart to the rest of the body, had developed a tear in its wall, weakening the vessel and putting the patient at risk of a life-threatening rupture. The surgery was performed by a team of cardiac surgeons led by Dr. Koushik Kannan, Consultant – Cardiothoracic Surgeon, Prashanth Hospitals, Chennai and Dr. Sushma Nandipati, Senior Consultant – Cardiothoracic Anesthesia & Critical Care. The patient presented with severe chest pain and elevated blood pressure. Following an initial assessment, the medical team determined that immediate surgery was necessary. A team of cardiac specialists performed a complex procedure called a Modified Bentall procedure to replace the damaged section of the aorta near the heart. The surgery also involved replacing the aortic valve, reconnecting the arteries supplying blood to the heart muscle, and replacing part of the aortic arch, which carries blood towards the brain and upper body. During the procedure, the surgeons temporarily stopped blood circulation throughout the body to repair the damaged blood vessel. The patient’s body temperature was lowered to 18°C to help protect vital organs during this critical phase. Despite the complexity of the surgery, the team completed a crucial stage involving the joining of the replacement blood vessel in approximately 13 minutes. The patient recovered well, experienced no reported postoperative complications, and was discharged on the fifth day after surgery. Speaking about the case, Dr. Koushik Kannan, Consultant – Cardiothoracic Surgeon, Prashanth Hospitals, said, “The case was particularly challenging, as the aorta, the main blood vessel carrying blood from the heart to the rest of the body, had enlarged significantly and its wall had weakened due to a tear. The surgery required careful planning and precise coordination, particularly during the phase when blood circulation was temporarily stopped to repair the damaged vessel. Completing a critical stage of the surgery in approximately 13 minutes reflects the precision and coordination of the surgical
team. We are pleased that the patient recovered well and was discharged on the fifth day after surgery.”
About Prashanth Hospitals: Prashanth Hospitals is a multidisciplinary hospital that provides sophisticated and dedicated healthcare services by professionally trained experts. Prashanth Super- specialty Hospital at Velachery and Kolathur is one of the best- and well-known multi- specialty hospitals in Chennai. These facilities have well trained and skilled nursing staff who can take good care of the patients. The vision is to become an internationally renowned medical institute by providing excellent health care services to the patients, and the mission is to maintain the trust of the patient by providing good quality of health care. The values on which Prashanth Super-specialty Hospitals function are quality of care, respect, competence, the effectiveness of the treatment, safety, and creating health awareness among the people. Prashanth Super- specialty Hospitals also provides various health care packages for check-ups and diagnosis of any ailment and their treatments.
Chennai, 4 November 2026: Through timely surgical interventions and multidisciplinary care, MGM Healthcare successfully averted the need for lung transplantation in a 15-month-old boy from Russia who developed progressive respiratory failure due to multisystem Langerhans cell histiocytosis (LCH), a rare disorder characterised by the abnormal multiplication and accumulation of Langerhans cells in the body.
The child, airlifted from Russia, was admitted at MGM Healthcare, originally for bilateral lung transplantation due to severe lung involvement, characterised by extensive cystic lung disease, recurrent bilateral pneumothorax (collapse of the lungs caused by air leaking into the space around them), and progressive breathing difficulties.
However, the hospital’s multidisciplinary team decided to explore all viable surgical options before proceeding with lung transplantation, an irreversible and complex procedure. The team performed bullectomy, a procedure for the removal of large air-filled space from the lung and repeated chest drain procedures to remove trapped air from around the lungs and allow the lungs to re-expand. It also carried out thoracoscopic atypical lung resection, a minimally-invasive surgery to remove a diseased portion of the lung, rather than removing an entire lung lobe, for diagnosis and treatment. Following these interventions and close monitoring, the child’s respiratory condition improved significantly, and he is now doing well. The baby no longer requires a lung transplant.
The multidisciplinary team comprised specialists in cardiac critical care, haematology and haemato-oncology, paediatric pulmonology and surgery, infectious diseases, neurology, urology, dermatology, ENT, thoracic surgery and lung transplantation, along with physician assistants and the ICU staff. There was a prolonged hospital stay, from May through September 2026, as the baby required mechanical ventilation, multiple intercostal drains, advanced imaging, invasive monitoring, multidisciplinary critical care and repeated surgical interventions.
The team was led by Dr. K. R. Balakrishnan, Director, Institute of Heart and Lung Transplant and Mechanical Circulatory Support, and Dr. Suresh Rao K. G., Co-Director of the Institute of Heart and Lung Transplant and Mechanical Circulatory Support and Cardiac Critical Care.
In his comments, Dr. Balakrishnan said, “Multisystem LCH is a rare disorder in which abnormal cells can accumulate in different organs. When LCH affects the lungs, it can cause cystic changes and serious respiratory complications, sometimes necessitating consideration of lung transplantation. However, the course of pulmonary LCH can be unpredictable, and some children with severe lung involvement may recover with appropriate medical and supportive care. This case underscores the importance of continuous clinical reassessment and multidisciplinary decision-making before proceeding with an irreversible intervention such as lung transplantation.”
Dr. Suresh Rao commented, “Given the severity of the child’s lung condition, transplantation was a serious consideration. However, the child’s remarkable response to medical management and the recovery of the native lungs allowed us to avoid transplantation. For a child who had travelled all the way from Russia with the possibility of a lung transplant, this was an exceptionally gratifying outcome. It reinforces the principle that knowing when to proceed with transplantation is as important as having the expertise to perform it.”
Chennai, October 31, 2026: To raise awareness about liver health and encourage healthier lifestyles, MGM Healthcare organised a 2.5-km community cyclothon, “Pedal for Liver”, in association with Vada Chennai Cyclists. More than 150 cycling enthusiasts took part in the early-morning ride that is part of the hospital’s annual liver awareness initiative. This October, the hospital focuses on fatty liver disease.
The event was flagged off by Thiru. V.K Ramkumar, Hon’ble MLA, Annanagar Constituency in the presence of Dr. Thiagarajan Srinivasan, Senior Consultant and Director, Institute of Liver Diseases, Transplant & HPB Surgery, Mr. Pathmanaban, Chief Executive Officer and Mr. Rajesh Agarwala, Medical Service Director, MGM Healthcare.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), the new terminology for fatty liver disease, is closely linked with metabolic risk factors such as obesity, diabetes and high cholesterol, and sedentary lifestyles and often progresses without noticeable symptoms. It can lead to liver inflammation, fibrosis and advanced liver disease if left untreated.
In his comments, Dr. Thiagarajan Srinivasan, Senior Consultant and Director, Institute of Liver Diseases, Transplant & HPB Surgery, MGM Healthcare, said, “It is high time we give liver health the same importance as every other aspect of our well-being. Fatty liver disease often advances silently, so it is vital to detect it early, especially in individuals with high risk factors. FibroScan, a non-invasive assessment, evaluates liver stiffness, an indicator of fibrosis, and also estimates liver fat using the controlled attenuation parameter (CAP). However, the need for testing should be determined by a healthcare professional based on clinical assessment. Early identification, appropriate evaluation and timely lifestyle and medical intervention can stop progression and protect long-term liver health. Balanced nutrition, regular physical activity, limiting alcohol and maintaining a healthy weight go a long way. It is important to make small, consistent changes from today.”
“An expert panel of 20 doctors, including liver specialists, gastroenterologists, physicians, endocrinologists, surgeons and nutritionists, convened to set standards for diagnosing MASLD. The panel also worked to standardise the use of non-invasive tests such as FibroScan, and to define treatment, from diet and lifestyle changes to pharmacological therapy and bariatric surgery. To educate healthcare professionals on the same, the hospital has organised a Continuing Medical Education (CME) programme titled, ‘A practical update on Metabolic Dysfunction – Associated Steatotic Liver Disease’ on October 21. More than 120 doctors attended the programme to learn and spread awareness among one and all,” he added.
As part of the cyclothon, registered participants can avail themselves of a 50% discount coupon for FibroScan at the hospital. It is aimed at creating awareness about liver health assessment and the importance of taking timely, informed steps towards preventive care.
Through the cyclothon, MGM Healthcare aims to encourage the general public to incorporate physical activity and other healthier habits into their lifestyles. They reinforce their commitment to raising community health awareness, early identification of health risks and patient-centric preventive care. The message is simple “Ride for a cause. Raise awareness. Put liver health first!”
Chennai, October 29, 2026: Kauvery Hospital, Alwarpet, Chennai, has successfully treated severe aortic valve leakage, known as Pure Native Aortic Regurgitation (PNAR), in a 63-year-old man with a transcatheter aortic valve replacement (TAVR) procedure using the specialised HANCHOR valve. The condition was caused by a perforation in the patient’s native aortic valve leaflet. The patient also had a history of mitral valve replacement, adding to the complexity of the treatment. This is the first of its kind procedure where the HANCHOR valve has been used for TAVR in a patient presenting with this combination of clinical factors.
The aortic valve regulates blood flow from the heart into the aorta, the main artery that supplies blood to the body. When the valve does not close properly, blood flows backwards into the heart, a condition known as aortic regurgitation. In this patient, the leakage was severe and associated with a perforation in one of the valve’s leaflets, making treatment more complex.
Treating pure native aortic regurgitation through a catheter-based approach presents a specific challenge. Unlike aortic stenosis, in which calcium deposits can help secure a replacement valve, patients with pure native aortic regurgitation often have little or no calcification to support the implanted valve. This makes stable positioning and secure anchoring more difficult. The patient’s previous mitral valve replacement added another important consideration to the treatment planning.
The HANCHOR valve is designed to address the challenge of valve anchoring in pure native aortic regurgitation. It combines a balloon-expandable frame with a dedicated anchoring element made of nitinol, a flexible metal alloy. The anchoring mechanism is designed to engage the native valve leaflets and help stabilise the replacement valve, including in situations where the surrounding anatomy offers limited support.
During the TAVR procedure, the replacement valve was delivered through a catheter and positioned within the patient’s existing aortic valve. This minimally invasive approach allows doctors to replace the faulty valve without conventional open-heart valve replacement surgery, where clinically appropriate.
Following the procedure, the post-procedure assessment reported no residual aortic regurgitation, no valve stenosis (abnormal narrowing) and no paravalvular leak, which is leakage around the implanted valve. No significant abnormality in the heart’s electrical conduction was reported. The patient was discharged after three days.
Dr. Rajaram Ananantharaman, Senior Consultant Interventional Cardiologist Kauvery Hospital, Alwarpet, Chennai, said: “Pure native aortic regurgitation can be challenging to treat using a catheter-based approach because the limited calcium deposits in the native valve can make it difficult to secure a replacement valve. Also, the perforation of the aortic valve leaflet, combined with the patient’s history of mitral valve replacement, added further complexity to treatment planning. The HANCHOR valve’s dedicated anchoring mechanism helped us address the challenges of valve positioning. The immediate post-procedure findings were encouraging, with no residual aortic regurgitation or leakage around the implanted valve reported. This procedure demonstrates the importance of individualised treatment planning and specialised valve technology in managing complex structural heart conditions.”
Commenting on the treatment, Dr. Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, said, “At Kauvery, we are committed to advancing patient care through clinical expertise, innovation and the adoption of appropriate medical technologies. Success stories such as this highlight the importance of combining specialised treatment approaches with careful clinical assessment to address complex cardiac conditions. We continue to focus on bringing advanced treatment options to patients while maintaining the highest standards of patient safety and care.”
Chennai, October 29, 2026: In observance of World Stroke Day, MGM Healthcare organised a 3-kilometer umbrella walkathon titled ‘Stride for Stroke’, commencing from the hospital premises to raise awareness about the importance of timely medical intervention. More than 400 people, mainly stroke survivors and people who had been prevented from developing strokes, participated in the walkathon.
The event was flagged off by actress Ramya Subramanian in the presence of Dr. Roopesh Kumar , Director of Neurosurgery, Dr. Vasudevan , Clinical Lead & Senior Consultant, Dr. Srivarthan , Consultant Neurologist, and Dr. Aarthi Deepesh , Clinical lead of Interventional Radiology, MGM Healthcare.
A stroke is a medical emergency that occurs when brain cells begin to die due to an inadequate supply of oxygen and nutrients. It occurs when a blood vessel in the brain ruptures or blood flow to a part of the brain is interrupted. It affects an individual’s movement, speech, vision, memory, and ability to perform day-to-day activities. Since brain tissue begins to die within minutes, stroke management is extremely time-sensitive.
According to the World Stroke Organization, one in four people is at risk of stroke in their lifetime, and over 12 million people experience a stroke each year globally. It is one of the major causes of death and long-term disability.
That’s why World Stroke Day is observed annually on October 29 across the globe to raise awareness about stroke prevention, early recognition of its symptoms, and the importance of timely medical intervention. This year, the campaign focuses on ‘Every M1nute Counts’, with the call to ‘#ActFast’, highlighting the importance of recognising the symptoms quickly. The sooner treatment begins, the greater the possibility of recovery. At MGM Healthcare, World Stroke Day is observed with an umbrella walkathon in which people raise their umbrellas to raise stroke awareness. Through the walkathon, the hospital management aims to raise awareness about the golden time for stroke management, as more than 90% of stroke patients reach the hospital beyond the golden four-and-a-half-hour period, slowing down the treatment and recovery process. Some of the common stroke symptoms include facial deviation, arm drift, and speech difficulties.
In his comments, Dr. Roopesh Kumar said, “Stroke is more like a race against time, where every second can make a huge difference between recovery and lifelong disability. The sooner a stroke is recognised and treated, the higher the chances of minimising brain damage and preventing long-term disability. It is important to be aware of stroke warning signs, such as sudden weakness or numbness on one side of the body, facial drooping, difficulty speaking, or sudden loss of balance. It is also equally important to understand that conditions like high blood pressure, diabetes, and high cholesterol can significantly increase the risk of stroke. People should make lifestyle modifications and undergo regular health check-ups to prevent stroke.”
In his comments, Mr. Pathmanaban , Chief Executive Officer said, “As healthcare professionals, we understand that behind every stroke is a life, a family, and a future that deserves every possible chance. This World Stroke Day, let us come together to raise awareness, encourage preventive healthcare, recognise symptoms early, and ensure that no time is lost in seeking medical attention. Remember, when it comes to stroke, every second matters, every action counts, and acting fast can save a life.”
● Child presented with jaundice and was diagnosed with Langerhans Cell Histiocytosis with
severe liver dysfunction, with bilirubin levels rising to 10–12 mg/dL
● Modified low-dose chemotherapy achieved a 90–95% response, while recurrent UTIs led to the diagnosis and surgical correction of congenital vesicoureteric reflux before liver transplantation ● Following liver transplantation, the child received four additional rounds of chemotherapy and
is now free of LCH and recurrent urinary infections
Chennai, 30 th September, 2026: In yet another case highlighting the importance of a multidisciplinary approach in managing complex pediatric conditions, doctors at Rainbow Children’s Hospital successfully performed a liver transplant on a 3-year-old child diagnosed with the rare systemic disorder Langerhans Cell Histiocytosis (LCH), whose treatment was further complicated by an underlying congenital abnormality of kidneys causing recurrent urinary tract infections. The child’s treatment involved multiple specialties and required the medical team to address one clinical challenge after another before the child could safely undergo transplantation. The child was initially brought to Rainbow Children’s Hospital with complaints of jaundice. Investigations revealed LCH, a rare systemic disorder, with significant liver dysfunction. Given the severity of the liver involvement, the initial focus was on controlling the underlying LCH and improving the child’s condition before transplantation. Chemotherapy was therefore initiated. However, with the liver already severely compromised, the treatment itself had to be carefully adapted. The child was placed on a low-dose chemotherapy which showed only partial response. Now there is a significant advancement in the newer targeted therapy which resulted in a good response in the LCH. While this represented a significant response to treatment, the child’s clinical journey became more complex when he began developing recurrent urinary tract infections during chemotherapy. Rather than treating the infections as an isolated complication, the medical team investigated the underlying cause. Evaluation by the pediatric nephrology and urology teams revealed congenital vesicoureteric reflux, a condition in which urine flows backwards towards the kidneys, increasing the risk of recurrent infections. With a liver transplant being considered and the risk of infection, needing to be minimized, the urinary abnormality had to be addressed before transplantation. The child therefore underwent a successful ureteric reimplantation surgery to reposition the ureter and correct the underlying abnormality. A temporary stent was subsequently placed to support the urinary system and reduce the risk of further infections during the transplant process.
Navigating this intricate medical puzzle required seamless collaboration across multiple specialties. A dedicated expert team at Rainbow Children’s Hospital, comprising Pediatric Nephrologists, Pediatric Surgeons, Hepatologists, Pediatric Transplant Surgeons, Pediatric Hemato-Oncologists, and Pediatric Intensivists came together to execute a carefully staged treatment plan to manage the complications, determine the appropriate sequence of interventions, stabilise the child and prepare him for liver transplantation. Once the urinary abnormality had been corrected and the child was medically stabilised, the liver transplant was successfully performed approximately three weeks later. The child underwent a living donor liver transplant, receiving a portion of his father’s liver, who was found to be a suitable donor following detailed evaluation. The transplant was performed by Dr. Mettu Srinivas Reddy, Group Director – Department of Liver Transplantation & HPB Surgery, Rainbow Children’s Hospital, Chennai along with Dr. Somashekara H R, Senior Consultant – Pediatric Hepatology & Liver Transplantation, Rainbow Children’s Hospital, Guindy with the multidisciplinary team of doctors Dr. Prahlad N, Senior Consultant – Pediatric Nephrology & Kidney Transplant, Dr. Prasanna Gopal, Pediatric Transplant Surgeon, Dr. Nandhini G, Senior Consultant – Pediatric surgeon and Urologist, Dr. Karthik Narayanan R & Dr. Nataraj P, Consultants – Pediatric Intensive Care, Dr. Meena Sivasankaran, Consultant Pediatric Hemato-oncologist, and Dr. Sathish Chander, who led the anesthesiology department. The living donor liver transplant involved transplantation of the left lateral segment of the donor liver, with the procedure lasting approximately 10 hours. Following the transplant, the child was closely monitored for 8 weeks and after which he continued to receive disease-directed chemotherapy for LCH. He subsequently completed four additional rounds of chemotherapy, with follow-up evaluations showing no evidence of LCH and resolution of the recurrent urine infections. Speaking on the occasion, Dr. Somashekara H R, Senior Consultant – Pediatric Hepatology & Liver Transplantation, Rainbow Children’s Hospital, said, “This was an exceptionally complex case because we were not dealing with a single problem. We had to manage a rare systemic disease with severe liver involvement, while also dealing with the limitations that the liver dysfunction placed on chemotherapy. When recurrent infections emerged, we had to identify and correct the underlying urinary abnormality before the child could proceed to transplant. Each decision had to be carefully coordinated with the next. The involvement of our hemato-oncology, hepatology and liver transplant, nephrology and urology teams allowed us to address these challenges together and take the child through treatment in a planned and coordinated manner.” Adding on to this case, Dr. Mettu Srinivas Reddy, Group Director – Department of Liver Transplantation & HPB Surgery, Rainbow Children’s Hospital, said, “Performing a liver transplant in a 3.5-year-old child with significant liver involvement and multiple associated medical complications requires meticulous planning at every stage. Before transplantation, the child had to be stabilised and the recurrent infections and congenital
urinary abnormality had to be appropriately addressed. From the surgical perspective, ensuring that the child was medically optimized and ready for transplantation was critical.
The successful transplant was made possible through close coordination between the transplant, pediatric, oncology, nephrology and urology teams, followed by careful post-transplant monitoring and continued treatment for the underlying condition.” Elaborating on the treatment journey, Dr. Prahlad N, Senior Consultant – Pediatric Nephrology & Kidney Transplant, Rainbow Children’s Hospital, said, “Recurrent urinary infections added another significant challenge to the child’s treatment. Given the need for a liver transplant, it was important to identify the reason behind these repeated infections and address it beforehand. Our evaluation, along with the urology team, identified vesicoureteric reflux. Gross reflux in a immunocompromised child like him, negating reflux. This was done by continuous bladder drainage with a silicon folleys prior and after anti reflux surgery. Permanent Correction of this condition was important to reduce the risk of further infections and ensure that the child was medically optimized before transplantation. Managing these associated problems alongside the primary condition was an important part of preparing the child for the next stage of treatment.” Further to this, Dr. Nandhini G, Senior Consultant – Pediatric Surgeon and Urologist, Rainbow Children’s Hospital, Guindy, said, “Recurrent urinary infections became an important concern as the child was being prepared for liver transplantation. Further evaluation identified congenital vesicoureteric reflux, where urine flows backwards towards the kidneys, increasing the risk of repeated infections. We performed ureteric reimplantation surgery with stent placement to correct the abnormality and close monitoring. Addressing the urinary condition before transplantation was important to reduce the risk of further infections and ensure that the child was medically stable for the next stage of treatment. The child was subsequently able to proceed with the liver transplant after recovering from the procedure. About Rainbow Children’s Medicare Limited: Rainbow Children’s Medicare Limited has a network of 26 hospitals across 11 cities, supported by 6 outpatient clinics and 2 exclusive IVF centres, with a total capacity of 2,505 beds .Our Pediatric services operating under the brand “Rainbow Children’s Hospital” includes new-born and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including organ transplantation); whereas our women care services under “Birthright by Rainbow” offers perinatal care services which includes normal and complex obstetric care, multi-disciplinary foetal care, perinatal genetic and fertility care along with gynecology services. Rainbow Children’s Hospital built on strong fundamentals of a multidisciplinary approach with a full-time consultant-led clinical service along with 24/7 commitment in a child centric environment. The company follows a hub-and-spoke operating model where the hub hospital provides comprehensive outpatient, inpatient care, with a focus on tertiary and quaternary services, while the spokes provide 24/7 emergency care, large outpatient services and comprehensive obstetrics, pediatric inpatient and level 3 NICU services. This model is successfully operational at Hyderabad and is gaining traction in Bengaluru. The endeavor is to replicate this approach in Chennai and across the National Capital Region. Subsequently Rainbow intends to expand into tier-2 cities of Southern India.Rainbow Children’s Hospital embraces a unique doctor engagement model, where doctors work
exclusively on a full-time. The doctors work in teams and have 24/7 commitment, which is particularly important for children’s emergency, neonatal, pediatric intensive care services and to support pediatric retrieval services. The Company also operates the country’s largest pediatric DNB training programme in private healthcare, offering post graduate residential DNB and fellowship programmes.
புதிய மருத்துவமனைகள் அமைத்தல், ஏற்கனவே உள்ள மருத்துவமனைகளை மேம்படுத்துதல், நோயாளிகளுக்கான மருத்துவச் சேவைகளை எளிதாக அணுகும் வகையில் வசதிகளை உருவாக்குதல் உள்ளிட்ட முக்கியப் பொறுப்புகளை உபாசனா காமினேனி கொனிடெலா மேற்கொள்ள உள்ளார்.
அப்போலோ மருத்துவமனைகள் இந்தியா முழுவதும் தனது மருத்துவக் கட்டமைப்பை மேலும் விரிவுபடுத்தும் வகையில், உபாசனா காமினேனி கொனிடெலாவை Director – Projects பொறுப்பில் நியமித்துள்ளது. அப்போலோ குழுமத்தின் தலைமை நிர்வாகம், மருத்துவக் குழுக்கள் மற்றும் திட்டப் பங்குதாரர்களுடன் இணைந்து, இந்தியா முழுவதும் செயல்படுத்தப்பட உள்ள மருத்துவமனைத் திட்டங்களின் திட்டமிடல் மற்றும் செயல்படுத்தும் பணிகளில் அவர் கவனம் செலுத்த உள்ளார்.
புதிய மருத்துவமனைகள் அமைத்தல், ஏற்கனவே செயல்பட்டு வரும் மருத்துவமனைகளின் விரிவாக்கம் மற்றும் மேம்படுத்துதல், நோயாளிகளுக்கான பகுதிகளில் ஒரே மாதிரியான வடிவமைப்புத் தர நிலைகளை உருவாக்குதல் ஆகியவை அவரது முக்கியப் பொறுப்புகளாக இருக்கும்.
மேலும், மருத்துவமனைகளில் தெளிவான வழிகாட்டிப் பலகைகள், எளிதான வழிகள், திறமையான மருத்துவப் பிரிவுகளின் அமைப்பு மற்றும் நோயாளிகள் மற்றும் அவர்களது குடும்பத்தினருக்கு வசதியான அனுபவத்தை வழங்கும் வகையிலான வடிவமைப்பு ஆகியவற்றிலும் அவர் கவனம் செலுத்த உள்ளார்.
வடிவமைப்பு முதல் மருத்துவமனை திறப்பு வரை அனைத்து கட்டங்களிலும் திட்டப் பணிகள் சீராக நடைபெறுவதை உறுதி செய்யும் வகையில், திட்ட மேலாண்மை நடைமுறைகள், அறிக்கை தயாரித்தல் மற்றும் பல்வேறு குழுக்களுக்கு இடையிலான ஒருங்கிணைப்பை மேம்படுத்துவதிலும் உபாசனா பணியாற்ற உள்ளார்.
அப்போலோ மருத்துவமனைகளின் தற்போதைய விரிவாக்கத் திட்டத்தின் மொத்த மதிப்பிடப்பட்ட திட்டச் செலவு சுமார் ₹8,600 கோடி ஆகும். இதில் ஏற்கனவே செயல்பட்டு வரும் மருத்துவமனைகளில் மேற்கொள்ளப்படும் சுமார் ₹1,565 கோடி மதிப்பிலான Brownfield Expansion Projects அடங்கும்.
நாட்டின் முக்கிய நகரங்களில் அப்போலோவின் மருத்துவச் சேவைத் திறனை அதிகரிப்பதுடன், வேகமாக வளர்ந்து வரும் நகர்ப்புறப் பகுதிகளில் புதிய மருத்துவமனைகளை அமைப்பதும் இந்தத் திட்டத்தின் நோக்கமாகும்.
வெளியிடப்பட்டுள்ள திட்ட விவரங்களின்படி, ஹைதராபாத், டெல்லி NCR, சென்னை, மும்பை மற்றும் பெங்களூரு உள்ளிட்ட நகரங்களிலும், லக்னோ, வாரணாசி, இந்தோர், குவாஹாத்தி மற்றும் ராஞ்சி உள்ளிட்ட நகரங்களிலும் பல்வேறு திட்டங்கள் செயல்படுத்தப்பட உள்ளன. உபாசனாவின் நேரடிப் பொறுப்பின் கீழ் வரும் குறிப்பிட்ட திட்டங்கள் மற்றும் அவற்றுக்கான பட்ஜெட் விவரங்கள் அப்போலோ மருத்துவமனைகளால் பின்னர் உறுதி செய்யப்படும்.
இந்த விரிவாக்கத்தின் மூலம் உயர்தரமான மருத்துவச் சேவைகளை மக்களுக்கு மேலும் எளிதாகவும், அணுகக்கூடிய வகையிலும் கொண்டு செல்வதே அப்போலோவின் நோக்கமாகும். ஒவ்வொரு பகுதியிலும் அமைக்கப்படும் மருத்துவமனை, நோயாளிகளுக்கு ஒரு முறை மட்டுமே பயன்படும் மருத்துவ வசதியாக இல்லாமல், தொடர்ந்து அவர்களுக்குத் தேவையான சிகிச்சை மற்றும் சுகாதாரச் சேவைகளை வழங்கும் மையமாக செயல்படும்.
அதே நேரத்தில், மருத்துவர்கள், செவிலியர்கள் மற்றும் பல்வேறு மருத்துவத் துறைகளில் பணியாற்றும் திறமையான நிபுணர்களுக்கு வேலைவாய்ப்புகளை உருவாக்குவதுடன், அவர்களைச் சார்ந்துள்ள குடும்பங்களுக்கும் இந்த விரிவாக்கம் வாய்ப்புகளை உருவாக்கும்.
மருத்துவமனை சிகிச்சையுடன் நோய்த் தடுப்பு மற்றும் ஆரம்பகட்ட நோய் கண்டறிதல் சேவைகளையும் தொடர்ந்து ஒருங்கிணைத்து, மக்கள் தங்களது உடல்நலத்தைப் பற்றி அதிகப் பொறுப்புடன் செயல்படுவதற்கு உதவுவது அப்போலோவின் நோக்கங்களில் ஒன்றாகும்.
அணுகக்கூடிய மற்றும் மலிவான மருத்துவச் சேவைகளுடன், சிறந்த மருத்துவத் தரத்தை இணைத்து வழங்குவதன் மூலம், உலகம் முழுவதிலுமிருந்து நோயாளிகள் நம்பிக்கையுடன் சிகிச்சைக்காக இந்தியாவைத் தேர்வு செய்யும் வகையில் இந்தியாவின் மருத்துவத் துறையின் வளர்ச்சிக்கும் பங்களிப்பதே அப்போலோவின் நீண்டகால நோக்கமாகும்.
இதுகுறித்து உபாசனா காமினேனி கொனிடெலா கூறுகையில்:
“எனது தாத்தா டாக்டர் பிரதாப் சி. ரெட்டி, உலகத் தரம் வாய்ந்த மருத்துவச் சேவைகள் இந்திய மக்களுக்கு எளிதில் கிடைக்க வேண்டும் என்ற நம்பிக்கையின் அடிப்படையில் அப்போலோவை உருவாக்கினார். அவர் கொண்டிருந்த அந்த நம்பிக்கையை நாம் உருவாக்கும் புதிய மருத்துவமனைகளிலும், மேம்படுத்தும் மருத்துவ வசதிகளிலும் தொடர்ந்து கொண்டு செல்வதே எனது பொறுப்பு.
ஒரு மருத்துவமனையின் சிறந்த வடிவமைப்பு என்பது மனிதர்களை மையமாகக் கொண்டதாக இருக்க வேண்டும். நோயாளிகள் எந்தவிதக் குழப்பமும் இல்லாமல் தங்களுக்குத் தேவையான இடத்தை எளிதில் கண்டறிய வேண்டும். குடும்பத்தினர் ஆதரவுடன் இருப்பதாக உணர வேண்டும். அதே நேரத்தில், மருத்துவர்கள் மற்றும் சிகிச்சைக் குழுவினர் சிறப்பான மருத்துவச் சேவையை வழங்குவதற்கு உதவும் வகையில் மருத்துவமனையின் இடவசதிகள் அமைக்கப்பட வேண்டும்.
அப்போலோ தொடர்ந்து வளர்ந்து வரும் நிலையில், ஒவ்வொரு திட்டமும் அந்தப் பகுதி மக்களுக்குப் பயனுள்ளதாக இருக்க வேண்டும். எங்களுடன் பணியாற்றும் மக்களுக்கு அர்த்தமுள்ள வாய்ப்புகளை உருவாக்க வேண்டும். மேலும், மக்கள் தங்களது உடல்நலத்தைத் தங்களது கட்டுப்பாட்டுக்குள் எடுத்துக்கொள்ள உதவ வேண்டும்.
சிந்தனைமிக்க வடிவமைப்பு, அக்கறையுடன் வழங்கப்படும் மருத்துவச் சேவை மற்றும் இந்தியாவின் மருத்துவத் துறையின் சிறப்பு ஆகிய மூன்றையும் ஒருங்கிணைத்து உலகிற்கு நாம் என்ன சாதிக்க முடியும் என்பதை வெளிப்படுத்தும் மிகப்பெரிய வாய்ப்பு நமக்கு உள்ளது.” என்றார்.
Chennai, September 22, 2026: Marking a milestone in bringing advanced radiology closer to patients, MGM Healthcare Malar-Adyar, has introduced a set of innovations in CT imaging that enable early detection of cancer and heart disease. Combining deep-learning technology, advanced CT protocols and radiology expertise, these innovations enable CT examinations to be performed with substantially lower radiation doses while preserving or enhancing diagnostic information.
The hospital has combined ultra-low-dose CT chest screening, and low-dose CT coronary angiography with optimised clinical protocols to reduce radiation exposure while maintaining diagnostic quality. A key component of its CT imaging workflow is Delta, a deep-learning-based image reconstruction technology that enables diagnostically useful images to be reconstructed from scans acquired at substantially lower radiation doses and, in selected applications, with lower volumes of contrast. The innovations are primarily in clinical protocol design, workflow integration, image acquisition, reconstruction, quantitative analysis and the way advanced technologies are applied to patient care.
The hospital has performed 133 coronary CT examinations over a 10-day period using approximately 15 mL of contrast per examination, along with a low-radiation acquisition strategy. The approach is aimed at reducing both radiation exposure and contrast requirements while maintaining the image quality needed to assess the coronary arteries. The ultra-low-dose chest CT programme has been used for 260 patients. Of these, 179 subsequently underwent biopsy based on imaging findings, with 54 cancers identified in the screened cohort.
Speaking about the innovations, Dr. Samuel Reefath J, Senior Consultant & Lead Radiologist, said, “Every time we perform a CT examination, we have to ask two questions: Can we obtain the information the clinician needs? And can we do it with the least possible burden to the patient? That burden includes radiation, iodinated contrast, cost, time and sometimes even the anxiety associated with invasive investigations. We therefore wanted to move from a conventional approach of simply acquiring images towards precision imaging, obtaining the maximum clinically useful information with the minimum necessary exposure. This philosophy has driven our low-dose coronary CT, ultra-low-dose chest CT and our work in quantitative and AI-assisted imaging. We are not abandoning established CT principles. We work within accepted radiology and cardiovascular CT standards, while optimizing acquisition parameters for individual clinical situations.”
He added, “Modern CT and MRI scanners are capable of generating enormous volumes of highly detailed information. Deep Learning assists radiologists in analysing large volumes of imaging data and drawing attention to findings that may require closer evaluation. Deep Learning-based tools can support the identification of subtle abnormalities, assist in image analysis, and help organise and quantify information, allowing the radiologist to focus more closely on the clinical interpretation of the findings. The integration of these technologies is aimed at making radiology not only faster, but also more consistent, quantitative and clinically useful.”
Commenting on the innovations, Mr. Venugopal Bhat, Chief Operating Officer and Group Vice President – Strategic Initiatives, said, “Our vision is to move towards precision healthcare rather than simply more healthcare technology. Advanced imaging should ultimately answer three questions: Can we detect disease earlier? Can we characterise it more accurately? And can we do it more safely? We want MGM Healthcare Malar-Adyar to function not merely as a place where sophisticated scans are performed, but as a centre where advanced imaging is translated into earlier diagnosis and better clinical decision-making.”
He added that ultimately, the patient should gain earlier diagnosis, safer diagnosis and more precise diagnosis. “If we can detect cancer before symptoms develop, that potentially creates an opportunity for earlier treatment. If we can perform a coronary CT with substantially less contrast and radiation, we reduce the burden of the investigation. And if quantitative imaging and AI can help us extract information that is difficult to appreciate visually, we can potentially provide clinicians with more objective information. So, the final measure of innovation is not how sophisticated the scanner is. The final measure is whether the patient benefits,” he said.